University of Iowa at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
University of Iowa brings 26 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its work centres on antibody formulation stability and on targeted nanoparticles for cancer and eye disease. Projects range from how surfactants and counterions control antibody self-association to topical liposomes for a corneal disease and nanoparticle vaccines for melanoma.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
University of Iowa Iowa City, IA | |
Poster Mon Oct 26 9:30am–10:30am Effect of Microneedle Length and Array Density on the Transdermal Delivery of Naproxen Sodium and Caffeine Poster Mon Oct 26 9:30am–10:30am Heparin-Coated PAMAM/CpG G10 Nanoparticles Targeting Plasmacytoid Dendritic Cells Promotes Type I Interferon Mediated Immune Activation In Vitro Poster Mon Oct 26 11:30am–12:30pm Evaluating T-Cell Morphology Under Handling Stress Using Flow Imaging Microscopy Poster Mon Oct 26 11:30am–12:30pm Utilizing Alternative Counterions to Modulate Protein-Protein Interactions in Monoclonal Antibody Formulations Poster Mon Oct 26 12:30pm–1:30pm Evaluating Amorphous Solid Dispersion Formulation Strategies to Decrease Pill Burden Poster Mon Oct 26 2:30pm–3:30pm Understanding the Effects of Moisture on Compaction Behavior of Pellets Using Multiple Compression Models and Compaction Energetics Poster Mon Oct 26 3:30pm–4:30pm Bacterial Cellulose for Tissue Engineering: In Vivo Adjuvant Assessment and cRGD Surface Functionalization Talk Tue Oct 27 9:00am–9:30am Poster Tue Oct 27 9:30am–10:30am Interfacial and Solution-Phase Insights into Electrostatic and Excipient Binding-Mediated Modulation of a Self-Associating Biologic Poster Tue Oct 27 10:30am–11:30am Impact of Fc Glycans Remodeling on Self-Association of Monoclonal Antibodies Poster Tue Oct 27 10:30am–11:30am Stability Signatures across Trastuzumab, Radioimmunoconjugate, and Antibody-Drug Conjugate Modalities Poster Tue Oct 27 10:30am–11:30am Transferrin Receptor-Targeted Ubiquinol-Loaded PLGA Nanoparticles for Fuchs Endothelial Corneal Dystrophy (FECD) Poster Tue Oct 27 11:30am–12:30pm Targeted Nanoparticle Delivery of Dual Therapeutics for BRAF V600E-Mutated Melanoma Poster Tue Oct 27 12:30pm–1:30pm Anticancer Effects of Combining Paclitaxel with a Novel Moxifloxacin Derivative Using c-RGD-Targeted Nanoparticles in Endometrial Cancer Poster Tue Oct 27 12:30pm–1:30pm Direct Film Coating of Small, Irregular-Shaped Drug Crystals via Fluidized Bed Technology with FlexStream Processor Poster Tue Oct 27 12:30pm–1:30pm Engineering Multi-functional Pharmaceutical Cocrystals to Improve Drug Processability for Oral Solid Development Poster Tue Oct 27 1:30pm–2:30pm Ferroptosis Inhibition Drives Multi-System Therapeutic Strategy in Fuchs Endothelial Corneal Dystrophy: Insights from High-Throughput Screening of Repurposed Compounds Talk Tue Oct 27 1:30pm–2:30pm Poster Tue Oct 27 2:30pm–3:30pm Hydrating Mucoadhesive Powders: A Strategy to Improve Nasal Drug Delivery Poster Tue Oct 27 3:30pm–4:30pm Mitochondria-Targeted Hesperadin-Loaded Liposomes as a Therapeutic Approach for Chlorine‑Induced Airway Oxidative Stress Poster Wed Oct 28 10:30am–11:30am Context-Dependent Protective Effects of Polysorbate 80 on Monoclonal Antibody Particle Formation Poster Wed Oct 28 10:30am–11:30am Force Distribution and Contact Mechanics in Mini-Tablet Compaction: A Discrete Element Method Study Poster Wed Oct 28 10:30am–11:30am Surfactant Effects on Adsorption of a Low-Concentration Bispecific Antibody Poster Wed Oct 28 11:30am–12:30pm Therapeutic Effects of Combining PAMAM-PLGA Nanoparticles with a Melanoma Vaccine +/- anti-PD-1 in a Preclinical Melanoma Model Poster Wed Oct 28 11:30am–12:30pm Topical Liposomes Therapy for a Blinding and Polygenic Corneal Disease: A Non-invasive Alternative to Surgery |
Instantly find 20 buyers from University of Iowa
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction